Komori
Disclosure4587PeptiDream Inc.Pharmaceuticals

Notice Regarding Borrowing of Funds (Refinancing)

The company entered into a new syndicated loan agreement arranged by Mizuho Bank to repay its existing borrowings. The borrowing amount is ¥16.44 billion and the term is 7.5 years, with the aim of reducing interest expense and further stabilizing its financial base.

Worth reading
73In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
164.4
Hundreds of millions of yen
Wording
Definitive
How definitive the wording is.

Decision and Details

Board of Directors

Refinancing of the existing borrowings

Decision16 March 2026
Period Covered7.5 years
Implementation31 March 2026 (scheduled drawdown date)
Going forwardThe borrowing will be executed on 31 March 2026. If any change arises in the earnings forecast, the company will disclose it promptly.
AmountBorrowing amount: ¥16.44 billion
Reason

In light of external conditions and other factors, the refinancing will be carried out ahead of the repayment date for the existing borrowings, 28 March 2027. The proceeds will be used to repay the existing borrowings and to further stabilize the financial base, including by reducing interest expense.

Impact on Business Performance

This has already been reflected in the earnings forecast for the fiscal year ending December 2026, and there is no change to the earnings forecast. The company has determined that, as a result of entering into this refinancing agreement, no material uncertainty related to the going concern assumption exists.

Decision and Details
ItemDetails
Matter CoveredRefinancing of the existing borrowings
Decision-Making BodyBoard of Directors
Decision Date16 March 2026
Implementation Date31 March 2026 (scheduled drawdown date)
Period Covered7.5 years
AmountBorrowing amount: ¥16.44 billion
Impact on Business PerformanceThis has already been reflected in the earnings forecast for the fiscal year ending December 2026, and there is no change to the earnings forecast. The company has determined that, as a result of entering into this refinancing agreement, no material uncertainty related to the going concern assumption exists.
ReasonIn light of external conditions and other factors, the refinancing will be carried out ahead of the repayment date for the existing borrowings, 28 March 2027. The proceeds will be used to repay the existing borrowings and to further stabilize the financial base, including by reducing interest expense.
Related previous disclosures“Notice Regarding Borrowing of Funds” dated 22 March 2022; “Notice Regarding Borrowing of Funds” dated 9 November 2023; earnings forecast for the fiscal year ending December 2026 announced on 16 February 2026; financial results summary for the fiscal year ended December 2025
Future plansThe borrowing will be executed on 31 March 2026. If any change arises in the earnings forecast, the company will disclose it promptly.
Items this document does not state (2)
Quantity / scaleGoverning Rule

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To repay the borrowings ahead of their repayment date of 28 March 2027. In addition, in light of external conditions and other factors, to further stabilize the financial base, including by reducing interest expense.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Borrowing of Funds (Refinancing) | PeptiDream Inc. (4587) timely disclosure | Komori